Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2017-03-31 (9 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: MARQUETTE-LEZ-LILLE (59520), Nord
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DES FLANDRES : revenue, balance sheet and financial ratios
PHARMACIE DES FLANDRES is a French company
founded 9 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in MARQUETTE-LEZ-LILLE (59520),
this company of category PME
shows in 2025 a net income positive of 159 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DES FLANDRES (SIREN 829991702)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
158 589 €
159 908 €
205 492 €
219 599 €
209 449 €
194 468 €
189 345 €
124 505 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, PHARMACIE DES FLANDRES generates positive net income of 159 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2018-2025: 125 k€ -> 159 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
158 589 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 52%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 56%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
51.938%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
55.998%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DES FLANDRES
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
1014.402
493.831
302.307
212.998
159.982
102.236
74.215
51.938
Financial autonomy
7.824
14.845
22.286
27.903
33.362
42.879
48.904
55.998
Repayment capacity
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
51.942025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Average-8 pts over 3 years
In 2025, the debt ratio of PHARMACIE DES FLANDRES (51.94) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
56.0%2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Good+10 pts over 3 years
In 2025, the financial autonomy of PHARMACIE DES FLANDRES (56.0%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 128.36. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
128.361
Liquidity indicators evolution PHARMACIE DES FLANDRES
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
193.601
192.412
206.933
180.636
194.994
158.715
142.183
128.361
Interest coverage
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
128.362025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Watch-11 pts over 3 years
In 2025, the liquidity ratio of PHARMACIE DES FLANDRES (128.36) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Positioning of PHARMACIE DES FLANDRES in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE DES FLANDRES is estimated at
2 519 205 €
(range 1 709 544€ - 3 952 979€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
1709k€2519k€3952k€
2 519 205 €Range: 1 709 544€ - 3 952 979€
NAF 5 année 2025
Valuation method used
Net Income Multiple
158 589 €
×
15.9x
=2 519 205 €
Range: 1 709 544€ - 3 952 980€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DES FLANDRES with other companies in the same sector:
Frequently asked questions about PHARMACIE DES FLANDRES
What is the revenue of PHARMACIE DES FLANDRES ?
The revenue of PHARMACIE DES FLANDRES is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE DES FLANDRES profitable?
Yes, PHARMACIE DES FLANDRES generated a net profit of 159 k€ in 2025.
Where is the headquarters of PHARMACIE DES FLANDRES ?
The headquarters of PHARMACIE DES FLANDRES is located in MARQUETTE-LEZ-LILLE (59520), in the department Nord.
Where to find the tax return of PHARMACIE DES FLANDRES ?
The tax return of PHARMACIE DES FLANDRES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DES FLANDRES operate?
PHARMACIE DES FLANDRES operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart